Targeting SR-BI for cancer diagnostics, imaging and therapy
Scavenger receptor class B type I (SR-BI) plays an important role in trafficking cholesteryl esters between the core of high density lipoprotein and the liver. Interestingly, this integral membrane protein receptor is also implicated in the metabolism of cholesterol by cancer cells, whereby overexpr...
Main Authors: | Maneesha Amrita Rajora, Gang Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00326/full |
Similar Items
-
Emergence and impact of theranostic‐nanoformulation of triple therapeutics for combination cancer therapy
by: Amit Kumar Rajora, et al.
Published: (2024-02-01) -
Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy
by: Sangram Raut, et al.
Published: (2018-10-01) -
<sup>225</sup>Ac-rHDL Nanoparticles: A Potential Agent for Targeted Alpha-Particle Therapy of Tumors Overexpressing SR-BI Proteins
by: Tania Hernández-Jiménez, et al.
Published: (2022-03-01) -
Smart Multifunctional Theranostics: Simultaneous Diagnosis and Therapy of Cancer
by: Yadollah Omidi
Published: (2011-09-01) -
Editorial: Cancer genetics and epigenetics: theranostic targets and mechanisms
by: Aisha Farhana, et al.
Published: (2024-07-01)